Customs By-law No. 2200083
Reference: LI 2022/43
Document type: Customs By-Law No. 2200083
Enabling act: Customs Act 1901; Customs Tariff Act 1995
Date of issue: 28 June 2022
Signatory: Franco Alvarez Delegate of the Comptroller-General of Customs
Registration number: F2022L00860
Registration date: 29 June 2022


1. This by-law may be cited as Customs By-law No. 2200083.: 2. For the purposes of item 57 of Schedule 4 to the Customs Tariff Act 1995 (the Customs Tariff), goods of the following kind are prescribed: (a) the goods are active ingredients to be used in the manufacture of medicaments, vaccines and other goods (the manufactured goods ); (b) the manufactured goods, if imported, would be classified under Chapter 30 of Schedule 3 to the Customs Tariff; and (c) the manufactured goods are to be used in the treatment, prevention or to limit the severity of the disease known as COVID-19. (a) the goods are active ingredients to be used in the manufacture of medicaments, vaccines and other goods (the manufactured goods ); (b) the manufactured goods, if imported, would be classified under Chapter 30 of Schedule 3 to the Customs Tariff; and (c) the manufactured goods are to be used in the treatment, prevention or to limit the severity of the disease known as COVID-19. 3. For the purposes of paragraph 2, active ingredients means only those ingredients that give the manufactured goods their therapeutic or prophylactic effect. 4. For the avoidance of doubt, paragraph 2 does not apply if the active ingredients have already been manufactured into the final product of a medicament, vaccine or other good that, if imported, would be classified under Chapter 30. 5. In this by-law, the Customs Tariff Act 1995 means the Customs Tariff Act 1995, as amended or proposed to be altered.